The ever-expanding realm of robotics and augmented reality is witnessing a significant transformation, thanks largely to ...

In an extraordinary show of the power that Elon Musk now exercises over the United States government, last week he joined a ...

AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that support a wide moat. The strong replenishment of new drugs sets ...

As 2025 unfolds, changes across the patent landscape are unfolding. From agency leadership transitions to proposed legislation and evolving ...

K reports of America’s largest pharmaceutical companies show that they continue to avoid paying much, if any, U.S. corporate income tax.

Fish & Richardson bumped gross revenue up to nearly $520 million in 2024. President and CEO John Adkisson attributed the gain ...

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.

Among technologists who build digital tools or programs, it is increasingly common to use AI as part of design and development processes. But as deep learning models flex their technical muscles more ...

The advent of generative artificial intelligence has sent shock waves across industries, from the technical to the creative. AI systems that can ...

With the deadline for the public consultation on AI strategy approaching, OpenAI and Google have made their proposals to the ...

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...